NIMGenetics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 89

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

NIMGenetics General Information

Description

Provider of genetic diagnostic services intended to assist medical specialists in identifying clinical disorders. The company offers microarray technology, next-generation sequencing, array comparative genomic hybridization, fluorescence in situ hybridization, whole exome sequencing, and a bioinformatics pipeline, enabling medical centers to access high-resolution genomic data for clinical diagnosis and identify genetic abnormalities in stem cell products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Avenida Isla Graciosa 3, Planta 0
  • San Sebastián De Los Reyes
  • 28703 Madrid
  • Spain
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Avenida Isla Graciosa 3, Planta 0
  • San Sebastián De Los Reyes
  • 28703 Madrid
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NIMGenetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NIMGenetics‘s full profile, request access.

Request a free trial

NIMGenetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NIMGenetics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NIMGenetics‘s full profile, request access.

Request a free trial

NIMGenetics Investments (1)

NIMGenetics’s most recent deal was a Buyout/LBO with Gene Predictis. The deal was made on 13-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gene Predictis 13-Feb-2023 Buyout/LBO Laboratory Services (Healthcare)
To view NIMGenetics’s complete investments history, request access »

NIMGenetics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Gene Predictis Lausanne, Switzerland 2004

NIMGenetics FAQs

  • When was NIMGenetics founded?

    NIMGenetics was founded in 2007.

  • Where is NIMGenetics headquartered?

    NIMGenetics is headquartered in Madrid, Spain.

  • What is the size of NIMGenetics?

    NIMGenetics has 89 total employees.

  • What industry is NIMGenetics in?

    NIMGenetics’s primary industry is Laboratory Services (Healthcare).

  • Is NIMGenetics a private or public company?

    NIMGenetics is a Private company.

  • What is NIMGenetics’s current revenue?

    The current revenue for NIMGenetics is .

  • How much funding has NIMGenetics raised over time?

    NIMGenetics has raised $7.57M.

  • Who are NIMGenetics’s investors?

    Apposite Capital has invested in NIMGenetics.

  • When was NIMGenetics acquired?

    NIMGenetics was acquired on 05-Dec-2024.

  • Who acquired NIMGenetics?

    NIMGenetics was acquired by Veritas Intercontinental.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process